Robert Thomas Freeman - Oct 14, 2024 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert Thomas Freeman
Stock symbol
ALHC
Transactions as of
Oct 14, 2024
Transactions value $
-$350,872
Form type
4
Date filed
10/16/2024, 05:37 PM
Previous filing
Oct 10, 2024
Next filing
Oct 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale -$351K -30.5K -15.67% $11.50 164K Oct 14, 2024 See Footnote F1, F2, F3
holding ALHC Common Stock 865K Oct 14, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Date of Rule 10b5-1 plan adoption: 03/15/2024
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.25 to $11.71. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.